{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PRKN",
        "Protein_Change": {
          "ref": "R",
          "alt": "P",
          "position": 42
        },
        "variant_string_id": "PRKN R42P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkin is an E3 ubiquitin ligase involved in the ubiquitination pathway. Mutations in parkin can cause autosomal recessive juvenile Parkinson’s disease (ARJP).",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the role of parkin in the ubiquitination pathway and its relevance to ARJP."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses urea denaturation, thermal denaturation, and NMR spectroscopy to assess the stability and structure of the parkin Ubiquitin-like domain (Ubld).",
          "judgment": "Yes",
          "reasoning": "These assays are suitable for assessing the stability and structural changes in the Ubld, which is relevant to the disease mechanism."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Step 3a: Basic Controls and Replicates: Wild-type parkin Ubld and ubiquitin were used as controls. Multiple replicates were used for experiments involving urea and thermal denaturation.\n\nStep 3c: Variant Controls: Known pathogenic variants (e.g., R42P) and benign variants (e.g., K48A) were used as controls.",
          "judgment": "Yes",
          "reasoning": "Step 3a: Basic Controls and Replicates: Both wild-type and mutant proteins were used as controls, and the experiments were performed in multiple replicates.\n\nStep 3c: Variant Controls: The study used both pathogenic and benign variants as controls, enhancing the reliability of the functional data."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Not evaluated",
          "judgment": "Not evaluated",
          "reasoning": "No information provided in the paper"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The R42P mutation causes global unfolding of the parkin Ubld, leading to significant destabilization and decreased E3 ligase activity. This supports a strong pathogenic classification."
    },
    {
      "variant_id": {
        "Gene": "PRKN",
        "Protein_Change": {
          "ref": "K",
          "alt": "A",
          "position": 48
        },
        "variant_string_id": "PRKN K48A"
      },
      "functional_evidence_aim": "Benign",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkin is an E3 ubiquitin ligase involved in the ubiquitination pathway. Mutations in parkin can cause autosomal recessive juvenile Parkinson’s disease (ARJP).",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the role of parkin in the ubiquitination pathway and its relevance to ARJP."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses urea denaturation, thermal denaturation, and NMR spectroscopy to assess the stability and structure of the parkin Ubiquitin-like domain (Ubld).",
          "judgment": "Yes",
          "reasoning": "These assays are suitable for assessing the stability and structural changes in the Ubld, which is relevant to the disease mechanism."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Step 3a: Basic Controls and Replicates: Wild-type parkin Ubld and ubiquitin were used as controls. Multiple replicates were used for experiments involving urea and thermal denaturation.\n\nStep 3c: Variant Controls: Known pathogenic variants (e.g., R42P) and benign variants (e.g., K48A) were used as controls.",
          "judgment": "Yes",
          "reasoning": "Step 3a: Basic Controls and Replicates: Both wild-type and mutant proteins were used as controls, and the experiments were performed in multiple replicates.\n\nStep 3c: Variant Controls: The study used both pathogenic and benign variants as controls, enhancing the reliability of the functional data."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Not evaluated",
          "judgment": "Not evaluated",
          "reasoning": "No information provided in the paper"
        }
      ],
      "final_evidence_strength": {
        "type": "Benign",
        "strength": "BS3_supporting"
      },
      "overall_conclusion": "The K48A mutation has a minor effect on the stability of the parkin Ubld, with little impact on protein-protein interactions. This supports a benign classification."
    }
  ]
}